Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Spire Healthcare Group plc
  6. News
  7. Summary
    SPI   GB00BNLPYF73

SPIRE HEALTHCARE GROUP PLC

(SPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Form 8.3 - The Vanguard Group, Inc. : Spire Healthcare Group plc

06/10/2021 | 09:32am EDT
The Vanguard Group, Inc. ( ) 
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc 
10-Jun-2021 / 14:31 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
FORM 8.3 
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
Rule 8.3 of the Takeover Code (the "Code") 
 
1. KEY INFORMATION 
 
(a) Full name of discloser:                                                                        The Vanguard Group, 
                                                                                                   Inc. 
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): 
 
 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor 
and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:            Spire Healthcare 
                                                                                                   Group plc 
 Use a separate form for each offeror/offeree 
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity 
of offeror/offeree: 
(e) Date position held/dealing undertaken: 
                                                                                                   08 June 2021 
 For an opening position disclosure, state the latest practicable date prior to the disclosure 
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of 
any other party to the offer?                                                                      N/A 
 If it is a cash offer or possible cash offer, state "N/A" 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

                                                                                   1p ordinary 
Class of relevant security: 
 
 
 
 
                                                                                   Interests       Short positions 
 
                                                                                   Number    %     Number       % 
(1) Relevant securities owned and/or controlled:                                   9,961,937 2.48% 
(2) Cash-settled derivatives: 
 
 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 
 
                                                                                   9,961,937 2.48% 
 TOTAL: 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1 (c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

                           Purchase/sale 
Class of relevant security               Number of securities Price per unit 
 
1p ordinary                BUY           2,464                2.45 GBP 

(b) Cash-settled derivative transactions

                  Product       Nature of dealing 
Class of relevant description                                                            Number of reference  Price per 
security                        e.g. opening/closing a long/short position, increasing/  securities           unit 
                  e.g. CFD      reducing a long/short position 
 
 
 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

                                                                                   Type 
Class of      Product          Writing,            Number of securities Exercise                       Option money 
relevant      description e.g. purchasing,         to which option      price per  e.g.         Expiry paid/ received 
security      call option      selling, varying    relates              unit       American,    date   per unit 
                               etc.                                                European 
                                                                                   etc. 
 

(ii) Exercise

Class of relevant         Product description Exercising/ exercised 
security                                      against                      Number of securities Exercise price per unit 
                          e.g. call option 
 
 
 

(d) Other dealings (including subscribing for new securities)

                           Nature of dealing 
Class of relevant security                               Details Price per unit (if applicable) 
                           e.g. subscription, conversion 
 
 
 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to 
relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the 
disclosure and any party to the offer or any person acting in concert with a party to the offer: 
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or 
understandings, state "none" 
 
 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure 
and any other person relating to: 
(i) the voting rights of any relevant securities under any option; or 
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is 
referenced: 
If there are no such agreements, arrangements or understandings, state "none" 
 
 
 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?  NO 
Date of disclosure:  10 June 2021 
Contact name:        Shawn Acker 
Telephone number:    001-610-669-8989 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk. -----------------------------------------------------------------------------------------------------------------------

Category Code: RET - Spire Healthcare Group plc 
TIDM: 
LEI Code:      5493002789CX3L0CJP65 
Sequence No.:  110651 
EQS News ID:   1206742 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1206742&application_name=news 
 

(END) Dow Jones Newswires

June 10, 2021 09:31 ET (13:31 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -1.58% 33290.08 Delayed Quote.10.51%
SPIRE HEALTHCARE GROUP PLC -0.60% 250 Delayed Quote.62.48%
All news about SPIRE HEALTHCARE GROUP PLC
06/18FORM 8.3 - THE VANGUARD GROUP, INC.á : Spire Healthcare Group plc
DJ
06/18SPIRE HEALTHCAREá : Samson Rock Capital LLP - Form 8.3 - Spire Healthcare Group ..
PR
06/17MARKET CHATTER : Spire Healthcare Shareholder Toscafund to Reject Ramsay's Takeo..
MT
06/16FORM 8.3 - THE VANGUARD GROUP, INC.á : Spire Healthcare Group plc
DJ
06/16SPIRE HEALTHCAREá : Samson Rock Capital LLP - Form 8.3 - Spire Healthcare Group ..
PR
06/14FORM 8.3 - THE VANGUARD GROUP, INC.á : Spire Healthcare Group plc
DJ
06/14SPIRE HEALTHCAREá : Samson Rock Capital LLP - Form 8.3 - Spire Healthcare Group ..
PR
06/11FORM 8.3 - THE VANGUARD GROUP, INC.á : pire Healthcare Group plc
DJ
06/10FORM 8.3 - THE VANGUARD GROUP, INC.á : Spire Healthcare Group plc
DJ
06/10SPIRE HEALTHCAREá : Samson Rock Capital LLP - Form 8.3 - Spire Healthcare Group ..
PR
More news
Financials
Sales 2021 1 054 M 1 456 M 1 456 M
Net income 2021 18,5 M 25,6 M 25,6 M
Net Debt 2021 1 065 M 1 471 M 1 471 M
P/E ratio 2021 54,8x
Yield 2021 0,28%
Capitalization 1 012 M 1 397 M 1 398 M
EV / Sales 2021 1,97x
EV / Sales 2022 1,87x
Nbr of Employees 11 943
Free-Float 67,4%
Chart SPIRE HEALTHCARE GROUP PLC
Duration : Period :
Spire Healthcare Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPIRE HEALTHCARE GROUP PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 217,50 GBX
Last Close Price 252,50 GBX
Spread / Highest target -4,95%
Spread / Average Target -13,9%
Spread / Lowest Target -34,7%
EPS Revisions
Managers and Directors
NameTitle
Justinian Joseph Ash Chief Executive Officer & Executive Director
Jitesh Himatlal Sodha Chief Financial Officer & Executive Director
Ian Michael Cheshire Chairman
Alison Dickinson Group Clinical Director
Fergus Macpherson Group Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
SPIRE HEALTHCARE GROUP PLC62.48%1 397
AIER EYE HOSPITAL GROUP CO., LTD.12.16%54 269
FRESENIUS SE & CO. KGAA19.44%29 873
TOPCHOICE MEDICAL CORPORATION39.23%19 130
IHH HEALTHCARE6.55%12 376
BANGKOK DUSIT MEDICAL SERVICES0.00%11 605